HitGen Forms Another Drug Discovery Partnership — This One with Sanofi

Life Science

Wuxi AppTec to Proceed With Trials of Targeted Anti-Hepatoma Drug

Life Science

For US pot companies, Canada is the land of opportunity

Cannabis, Life Science

Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307

Life Science

I-Mab Out-Licenses Bi-Specific to South Korea’s ABL Bio in $100 Million Deal

Life Science

KEYTRUDA® (pembrolizumab) is the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma

Life Science

Chinese Educator to Take 10% Stake in South Korea’s Chungdahm Learning

Life Science

Life Science & Technology Weekly 153 – Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer

Life Science, Technology

GlaxoSmithKline strikes $300 million deal with 23andMe for genetics-driven drug research

Life Science

Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory

Life Science

Terumo Pays $130 Million to Acquire Essen, a Beijing Stent Company

Life Science

‘Breakthrough’ in South Korea as cannabis law gets major backer

Cannabis, Life Science

Hillhouse Capital Leads $230M Series B Preferred Stock Financing In US Biopharmaceutical Firm Gossamer Bio

Life Science

Pfizer Plans $465 Million Project in Michigan, Part of its $5 Billion Manufacturing Plan

Life Science

Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer

Life Science